+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiparasitic Drugs Market - Global Forecast 2026-2032- Product Image
Antiparasitic Drugs Market - Global Forecast 2026-2032- Product Image
New

Antiparasitic Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715672
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antiparasitic drugs market is undergoing significant transformation, shaped by advances in science, tightening regulatory environments, and evolving expectations from stakeholders across animal health sectors. This report synthesizes these developments to provide senior leaders with the strategic insights needed to strengthen competitive positioning and operational resilience.

Market Snapshot: Antiparasitic Drugs Market Overview

The Antiparasitic Drugs Market grew from USD 22.18 billion in 2025 to USD 23.30 billion in 2026. It is expected to continue growing at a CAGR of 4.88%, reaching USD 30.98 billion by 2032. Market expansion is driven by the emergence of resistance, regulatory intensification, and the evolving needs of veterinary and producer stakeholders. Industry participants must respond with agile R&D, enhanced formulation technologies, and adaptive supply strategies to capture demand in both established and emerging regions.

Scope & Segmentation

  • Drug Classes: Amino-Acetonitrile derivatives (e.g., Monepantel), Benzimidazoles (Albendazole, Fenbendazole, Mebendazole, Oxibendazole, Thiabendazole), Macrocyclic Lactones (Abamectin, Doramectin, Eprinomectin, Ivermectin), Spiroindoles (Derquantel)
  • Veterinary End Uses: Aquaculture (Fish, Shrimp), Companion Animals (Canine, Feline), Livestock (Cattle, Poultry, Swine)
  • Technologies: Targeted formulations, combination regimens, point-of-care diagnostics, digital health integration, environmental residue mitigation
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific

Key Takeaways

  • Biological resistance is altering product positioning, requiring ongoing investment in novel chemotypes and combined treatment strategies.
  • Regulatory agencies are raising expectations on residues, withdrawal periods, and environmental impact, driving changes in product labeling and stewardship protocols.
  • Veterinary and producer demand now emphasizes solutions that offer efficacy, cost-effectiveness, administration simplicity, and compliance with animal welfare and sustainability standards.
  • Supply chain shifts, including regional manufacturing, API sourcing diversification, and longer-term contracts, are being adopted to counter trade and tariff volatility.
  • Segment-specific approaches—for aquaculture, companion animal, and livestock applications—are necessary to align with end user requirements and local regulatory climates.
  • Manufacturers benefit from partnerships with diagnostic and digital health providers to enable precise, data-driven interventions and increase customer retention.

Tariff Impact

Industry participants are navigating increased tariffs on active pharmaceutical ingredients and finished dose forms. These cost pressures have prompted the adoption of diversified sourcing, nearshoring manufacturing operations, and strategic procurement agreements. In response, firms are re-sequencing product launches by geography, internalizing aspects of API synthesis, and building capacity in tariff-favored locations. The result is a reconfigured supply chain designed to manage pricing power and protect product availability despite ongoing global trade fluctuations.

Methodology & Data Sources

This analysis is grounded in primary interviews with industry executives, regulatory specialists, procurement leaders, and field veterinarians. These insights are integrated with secondary literature, detailed regulatory reviews, and supply chain mapping. Triangulation ensures that strategic recommendations reflect a comprehensive understanding of market drivers and operational realities identified across multiple independent sources.

Why This Report Matters

  • Clarifies the disruption and opportunity created by new resistance patterns, changing regulatory frameworks, and evolving retail and production channels.
  • Provides practical, prioritized action items for accelerating innovation, ensuring responsible stewardship, and securing supply chain resilience across segments.
  • Enables decision-makers to benchmark operational strategies and investment priorities against best-in-class commercial and regulatory practices.

Conclusion

To sustain their positions in the antiparasitic therapeutics market, industry leaders must integrate science-led development with operational agility and stewardship. Coordinated efforts in innovation, supply chain management, and stakeholder engagement remain central to enduring therapeutic effectiveness and commercial relevance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Antiparasitic Drugs Market, by Drug Class
8.1. Benzimidazoles
8.1.1. Albendazole
8.1.2. Fenbendazole
8.1.3. Mebendazole
8.1.4. Oxibendazole
8.1.5. Thiabendazole
8.2. Macrocyclic Lactones
8.2.1. Abamectin
8.2.2. Doramectin
8.2.3. Eprinomectin
8.2.4. Ivermectin
9. Antiparasitic Drugs Market, by Veterinary
9.1. Aquaculture
9.1.1. Fish
9.1.2. Shrimp
9.2. Companion Animals
9.2.1. Canine
9.2.2. Feline
9.3. Livestock
9.3.1. Cattle
9.3.2. Poultry
9.3.3. Swine
10. Antiparasitic Drugs Market, by By Spectrum of Activity
10.1. Broad-spectrum antiparasitics
10.2. Narrow-spectrum antiparasitics
11. Antiparasitic Drugs Market, by Route of Administration
11.1. Oral
11.2. Injectable
12. Antiparasitic Drugs Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Antiparasitic Drugs Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Antiparasitic Drugs Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Antiparasitic Drugs Market
16. China Antiparasitic Drugs Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 60 Degrees Pharmaceuticals
17.6. Alkem Laboratories Limited
17.7. Aurobindo Pharma
17.8. Bayer AG
17.9. Cipla Limited
17.10. Eisai Co Ltd
17.11. Elanco Animal Health Incorporated
17.12. Fresenius Kabi AG
17.13. GlaxoSmithKline plc
17.14. Glenmark Pharmaceuticals Limited
17.15. Ipca Laboratories Ltd
17.16. J.B. Chemicals and Pharmaceuticals Limited
17.17. Johnson & Johnson
17.18. Lupin Limited
17.19. Mankind Pharma Ltd
17.20. Merck & Co Inc
17.21. Merck KGaA
17.22. Novartis AG
17.23. Pfizer Inc
17.24. Sanofi S.A.
17.25. Sun Pharmaceutical Industries Ltd
17.26. Takeda Pharmaceutical Company Limited
17.27. Viatris Inc
17.28. Zydus Lifesciences Ltd
List of Figures
FIGURE 1. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ALBENDAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ALBENDAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ALBENDAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FENBENDAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FENBENDAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FENBENDAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MEBENDAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MEBENDAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MEBENDAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OXIBENDAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OXIBENDAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OXIBENDAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY THIABENDAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY THIABENDAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY THIABENDAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ABAMECTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ABAMECTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ABAMECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DORAMECTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DORAMECTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DORAMECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY EPRINOMECTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY EPRINOMECTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY EPRINOMECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY IVERMECTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY IVERMECTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY IVERMECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SHRIMP, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CANINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CANINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FELINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FELINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 131. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 135. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 149. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 150. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 151. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 153. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 155. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 156. AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 170. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 171. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 172. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 174. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 176. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 177. ASEAN ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 180. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 181. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 182. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 183. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 184. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 185. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 186. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 187. GCC ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 200. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 201. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 202. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 203. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 204. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 205. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 206. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 207. BRICS ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 210. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 211. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 212. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 213. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 214. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 215. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 216. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 217. G7 ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 220. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 221. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 222. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 223. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 224. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 225. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 226. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 227. NATO ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. CHINA ANTIPARASITIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 241. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2032 (USD MILLION)
TABLE 242. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2032 (USD MILLION)
TABLE 243. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 244. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 245. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 246. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 247. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY BY SPECTRUM OF ACTIVITY, 2018-2032 (USD MILLION)
TABLE 248. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Antiparasitic Drugs market report include:
  • 60 Degrees Pharmaceuticals
  • Alkem Laboratories Limited
  • Aurobindo Pharma
  • Bayer AG
  • Cipla Limited
  • Eisai Co Ltd
  • Elanco Animal Health Incorporated
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Ipca Laboratories Ltd
  • J.B. Chemicals and Pharmaceuticals Limited
  • Johnson & Johnson
  • Lupin Limited
  • Mankind Pharma Ltd
  • Merck & Co Inc
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc
  • Zydus Lifesciences Ltd

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.98 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Antiparasitic Drugs Market Report 2025 - Product Image

Antiparasitic Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Pets Anti-infective Drugs Market - Global Forecast 2026-2032 - Product Image

Pets Anti-infective Drugs Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Anti-infectives Market - Global Forecast 2026-2032 - Product Image

Anti-infectives Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Albendazole Veterinary - Global Strategic Business Report - Product Image

Albendazole Veterinary - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Infectious Disease Therapeutics - Global Strategic Business Report - Product Image

Infectious Disease Therapeutics - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From

About the Antiparasitic Agent Market

The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most effective treatment. The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.